Trofosfamide
Product Specifications
UNSPSC Description
Trofosfamide is an orally bioavailable oxazaphosphorine derivative with antineoplastic activity[1].
Target Antigen
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/trofosfamide.html
Purity
98.0
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
ClCCN1P(OCCC1)(N(CCCl)CCCl)=O
Molecular Weight
323.58
References & Citations
[1]Witte HM, et al. Trofosfamide in the treatment of elderly or frail patients with diffuse large B-cell lymphoma. J Cancer Res Clin Oncol. 2019 Jan;145(1):129-136.|[2]Görn M, et al. A pilot study of docetaxel and trofosfamide as second-line 'metronomic' chemotherapy in the treatment of metastatic non-small cell lung cancer (NSCLC). Onkologie. 2008 Apr;31(4):185-9.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-119824/Trofosfamide-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-119824/Trofosfamide-SDS-MedChemExpress.pdf
Clinical Information
Launched
CAS Number
22089-22-1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
